Aurinia Pharmaceuticals Inc (AUPH)

EBITDA Margin

65.57%

Quarterly · Period ending:

AUPH logo

AUPH EBITDA Margin

Latest reported65.57%
AUPH Quarterly EBITDA Margin (-33.33% → 65.57%)
High-resolution chart · PNG

AUPH ebitda margin history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aurinia Pharmaceuticals Inc EBITDA Margin — Quarterly
Period endingEBITDA Margin
65.5708%
64.0281%
61.0369%
50.1266%
40.1911%
48.4623%
11.9949%
30.851%
13.1469%
-7.7133%
-44.699%
-11.8995%
-27.3534%
-72.8094%
-87.8213%
-12.9547%
-122.9683%
-170.0902%
-136.3357%
-337.3628%
-697.0393%
-5,484.3545%
-19.1045%
-144,727.5862%
-90,931.0345%
-82,820%
-262,034.4828%
-8,093.0435%
-53,413.7931%
-40,070%
-49,337.931%
-4,782.4%
-52,772.4138%
-50,263.3333%
-39,670.9677%
-46,303.4483%
-2,941.9453%
-32,912.9032%
-25,533.3333%
-16,219.3548%
-7,612.7273%
-7,824.5614%
-14,994.7368%
-10,515.7895%
-9,642.3729%
-8,351.6129%
-6,630.8824%
-5,245.8333%
-5,883.0986%
-4,991.0448%
-113.9654%
-3,576.1715%
-1,025.5542%
-776.2395%
-5,777.9795%
-1,686.0499%
-1,920.019%
-4.1207%
2,023.3616%
-163.9642%
3,355.9715%
-1,124.6338%
-756.273%
-439.589%
-14.8993%
-47.7642%
-83.5312%
-166.0884%
-369.6055%
-384.3331%
-961.393%
-127.9273%
-940.1943%
-860.7948%
-1,389.6733%
-1,403.9869%
-2,189.4994%
-1,105.866%
-910.2444%
-1,193.4506%
-619.9235%
-329.9501%
788.2064%
-366.5207%
-3,224.4153%
-2,185.4172%
-3,120.1157%
-2,364.2218%
-1,291.4708%
-647.3091%
-778.8605%
-1,245.0605%
31.7344%
-1,382.968%
-929.2752%
44.2088%
45.3085%
-103.0174%
-442.0996%
-609.3454%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.